Answers are grounded in this paper and cite their sources.
Background: genotyping data imputed from microarrays, rather than direct measurement of high-resolution genotypes. Objective: associations we undertook a PheWAS in many previously understudied health conditions. Methods: ). After stratifying according to ancestry, we performed a logistic regression analysis adjusting for sex and age for HLA-phenotype association. Results: alleles in immune-mediated disease. The vast majority of these novel associations were replicated in the independent All of Us cohort, confirming the validity of this approach. Conclusion: genotypes with phenotyping beyond the EHR to reveal immunogenetic influences on common health outcomes. They also point to immediate translational avenues - particularly for drug hypersensitivity - while motivating future functional studies and prospective clinical validation to refine mechanistic understanding and clinical utility.
No takes yet. Share an insight, caveat, or question.
Boquett et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: